Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


COVID-19: Daily Top 10 Papers


  Schizophrenia

  Free Subscription


31.05.2021

1 Acta Psychiatr Scand
2 J Clin Psychiatry
1 Mol Psychiatry
1 Neuropsychology
1 PLoS Comput Biol
2 PLoS One
1 Proc Natl Acad Sci U S A
1 Psychiatry Res
3 Psychol Med
8 Schizophr Res


  Retrieve available abstracts of this week’s articles:
HTML format
 
 
Single Articles


    Acta Psychiatr Scand

  1. SHOHAM N, Eskinazi M, Hayes JF, Lewis G, et al
    Associations Between Psychosis and Visual Acuity Impairment: A Systematic Review and Meta-Analysis.
    Acta Psychiatr Scand. 2021 May 24. doi: 10.1111/acps.13330.
    PubMed         Abstract available


    J Clin Psychiatry

  2. KANE JM
    Lessening the Side Effect Burden to Improve Adherence Among Individuals With Schizophrenia.
    J Clin Psychiatry. 2021;82.
    PubMed         Abstract available

  3. HARVEY PD
    Patient-Centered Treatment Strategies to Improve Outcomes in Schizophrenia.
    J Clin Psychiatry. 2021;82.
    PubMed         Abstract available


    Mol Psychiatry

  4. DI BIASE MA, Cetin-Karayumak S, Lyall AE, Zalesky A, et al
    White matter changes in psychosis risk relate to development and are not impacted by the transition to psychosis.
    Mol Psychiatry. 2021 May 24. pii: 10.1038/s41380-021-01128.
    PubMed         Abstract available


    Neuropsychology

  5. CAMARA S, Contador I, Herrero P, Ruisoto P, et al
    The role of education in executive functions, behavioral problems and functional performance in people with schizophrenia.
    Neuropsychology. 2021;35:366-373.
    PubMed         Abstract available


    PLoS Comput Biol

  6. CALVIN OL, Redish AD
    Global disruption in excitation-inhibition balance can cause localized network dysfunction and Schizophrenia-like context-integration deficits.
    PLoS Comput Biol. 2021;17:e1008985.
    PubMed         Abstract available


    PLoS One

  7. LINCOLN SH, Johnson T, Kim S, Edenbaum E, et al
    Psychosis proneness, loneliness, and hallucinations in nonclinical individuals.
    PLoS One. 2021;16:e0251753.
    PubMed         Abstract available

  8. KOBORI A, Miyashita M, Miyano Y, Suzuki K, et al
    Advanced glycation end products and cognitive impairment in schizophrenia.
    PLoS One. 2021;16:e0251283.
    PubMed         Abstract available


    Proc Natl Acad Sci U S A

  9. PAK C, Danko T, Mirabella VR, Wang J, et al
    Cross-platform validation of neurotransmitter release impairments in schizophrenia patient-derived NRXN1-mutant neurons.
    Proc Natl Acad Sci U S A. 2021;118.
    PubMed         Abstract available


    Psychiatry Res

  10. GUILLAUME F, Thomas E
    Recollection and familiarity in schizophrenia:An ERP investigation using face recognition exclusion tasks.
    Psychiatry Res. 2021;302:113973.
    PubMed         Abstract available


    Psychol Med

  11. O'DONOGHUE B, Lyne J, Roche E, Mifsud N, et al
    Risk of first-episode psychosis in migrants to the Republic of Ireland.
    Psychol Med. 2021 May 25:1-8. doi: 10.1017/S003329172100177.
    PubMed         Abstract available

  12. LINDGREN M, Kuvaja H, Jokela M, Therman S, et al
    Predictive validity of psychosis risk models when applied to adolescent psychiatric patients.
    Psychol Med. 2021 May 24:1-12. doi: 10.1017/S0033291721001938.
    PubMed         Abstract available

  13. STAFFORD J, Dykxhoorn J, Sommerlad A, Dalman C, et al
    Association between risk of dementia and very late-onset schizophrenia-like psychosis: a Swedish population-based cohort study.
    Psychol Med. 2021 May 25:1-9. doi: 10.1017/S0033291721002099.
    PubMed         Abstract available


    Schizophr Res

  14. MOXAM AB, McClellan EJ, Cagande C, Calkins ME, et al
    Few primary care pediatricians screen for psychosis but many are willing.
    Schizophr Res. 2021;232:65-67.
    PubMed        

  15. WELLESLEY WESLEY E, Patel I, Kadra-Scalzo G, Pritchard M, et al
    Gender disparities in clozapine prescription in a cohort of treatment-resistant schizophrenia in the South London and Maudsley case register.
    Schizophr Res. 2021;232:68-76.
    PubMed         Abstract available

  16. HEGELSTAD WTV, Berg AO, Bjornestad J, Gismervik K, et al
    Childhood interpersonal trauma and premorbid social adjustment as predictors of symptom remission in first episode psychosis.
    Schizophr Res. 2021;232:87-94.
    PubMed         Abstract available

  17. WANG D, Zhuo K, Sun Y, Xiang Q, et al
    Middle temporal corpus callosum impairment as a predictor of eight-week treatment outcome of drug-naive first-episode psychosis patients: A pilot longitudinal study.
    Schizophr Res. 2021;232:95-97.
    PubMed        

  18. FORTEA A, Batalla A, Radua J, van Eijndhoven P, et al
    Cortical gray matter reduction precedes transition to psychosis in individuals at clinical high-risk for psychosis: A voxel-based meta-analysis.
    Schizophr Res. 2021;232:98-106.
    PubMed         Abstract available

  19. SENGUTTA M, Karow A, Moritz S
    Deconstruction of a screening questionnaire for prodromal psychosis to reduce false positive responses.
    Schizophr Res. 2021;232:107-108.
    PubMed        

  20. ZHANG YJ, Pu CC, Wang YM, Zhang RT, et al
    Social brain network correlates with real-life social network in individuals with schizophrenia and social anhedonia.
    Schizophr Res. 2021;232:77-84.
    PubMed         Abstract available

  21. LISOWAY AJ, Chen CC, Zai CC, Tiwari AK, et al
    Toward personalized medicine in schizophrenia: Genetics and epigenetics of antipsychotic treatment.
    Schizophr Res. 2021;232:112-124.
    PubMed         Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Schizophrenia is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: